Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

PATH vs CFLT: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

CFLT Captures Overall Composite Edge (62.8 BUY vs 58.3 HOLD), While PATH Leads 4–2 on Growth & Valuation Pillars

CFLT Overall Winner 6-Pillar Tally: PATH 4 – 2 CFLT Matrix Metrics: PATH 5 – 5 CFLT

As of Nov 16, 2026, Confluent, Inc. (CFLT) captures the overall head-to-head institutional edge over UiPath, Inc. (PATH) on higher Unified Composite conviction (62.8/100 BUY vs. 58.3/100 HOLD) after splitting the core matrix 5–5 (led by Growth & Scale, Options & Positioning), while PATH wins 4–2 across the 6-pillar growth and valuation breakdown. PATH trades at $13.24 (17.4x Forward P/E, 9.4% operating margin) versus CFLT at $30.99 (46.7x Forward P/E, -27.5% operating margin).

  • Growth vs. Quality Trade-Off: CFLT earns the overall head-to-head edge with a stronger Unified Composite Score (62.8/100 BUY vs. PATH 58.3/100 HOLD) and 0.99β · 4% Vol risk profile, whereas PATH leads top-line expansion (+13.4% YoY revenue growth, 0.41x PEG, and 4 of 6 institutional pillars) for higher-beta growth mandates.
  • Technical & Structure Timing Caution: PATH is currently in a Weinstein Distribution regime near a flattening 50-day moving average and Breakdown options structure phase (RSI 47.4); meanwhile CFLT trades in a Markup technical trend (UNCLASSIFIED options phase, RSI 72.9). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About PATH vs CFLT
PATH NYSE
UiPath, Inc.
Services-Prepackaged Software
$13.24
-0.19% 1D
Market Cap $6.8B
TTM Revenue $1.72B
Forward P/E 17.4x
Beta / 30D Vol 0.86β · 30% Vol
Unified Composite Score
58.3 / 100 HOLD
Tech 74.0 Fund 68.0 Flow 68.0 Mom 60.0
Weinstein Technical Phase Distribution · Trim / tighten stop
Price near a flattening SMA50 (slope -8.7%) with fading momentum, RSI 47
RSI-14: 47.4 · SMA20: $13.49 · SMA50: $13.38
CFLT NASDAQ Head-to-Head Winner
Confluent, Inc. Class A Common Stock
Services-Prepackaged Software
$30.99
+1.04% 1D
Market Cap $11.0B
TTM Revenue $1.17B
Forward P/E 46.7x
Beta / 30D Vol 0.99β · 4% Vol
Unified Composite Score
62.8 / 100 BUY
Tech 60.0 Fund 58.0 Flow 69.0 Mom 40.0
Weinstein Technical Phase Markup · Hold / add on dips
Price above SMA50, rising 50-day trend (2.3% over 20 days), RSI 73
RSI-14: 72.9 · SMA20: $30.72 · SMA50: $30.56

6-Pillar Scorecard Institutional Category Breakdown (PATH 4 – 2 CFLT)

Columns: Metric · PATH · CFLT
1. Valuation Multiples PATH
Forward P/E 17.4x 46.7x
Trailing P/E 19.6x 61.4x
PEG Ratio 0.41x 2.16x
EV / Revenue 3.7x 9.4x
2. Growth & Scale CFLT
Revenue Growth (YoY) +13.4% +20.5%
Earnings Growth (YoY) N/A +0.0%
TTM Revenue (USD) $1.72B $1.17B
Market Cap $6.8B $11.0B
3. Profitability & Quality PATH
Gross Margin 82.6% 74.3%
Operating Margin 9.4% -27.5%
Net Profit Margin 21.0% -25.3%
Return on Equity (ROE) 20.0% -27.7%
4. Balance Sheet & Cash Flow PATH
Cash Generation (TTM) $363M -$338M EBITDA
Cash Flow Margin 21.1% -29.0% EBITDA Mgn
Net Cash / Leverage $528M Net Cash $3.28 Book/Sh · -27.7% ROE
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning CFLT
Options Structure Phase BREAKDOWN UNCLASSIFIED
Current IV / %ile 50.3% (11th %ile) 0.2% (<1st %ile)
Put/Call OI Skew 0.49x (Call-Skewed) N/A
OBV Trend / Tech Phase DISTRIBUTION · Distribution NEUTRAL · Markup
6. R&D & Supply-Chain Moat PATH
OpEx & R&D Intensity 73.2% of Rev ($1.26B) N/A
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Scale & Operating Efficiency Moat Cyclical / Execution-Driven Positioning
Supply-Chain Role Software - Infrastructure Operator Software - Infrastructure Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: PATH (5) vs CFLT (5)
Institutional Metric PATH CFLT Criterion Row Edge
Market Capitalization
Scale
$6.8B $11.0B Larger Scale CFLT
Trailing P/E Ratio
Valuation
19.6x 61.4x Lower Multiple PATH
Forward P/E Ratio
Valuation
17.4x 46.7x Lower Multiple PATH
Revenue Growth (YoY)
Growth
+13.4% +20.5% Higher Growth CFLT
Operating Margin (TTM)
Profitability
9.4% -27.5% Higher Margin PATH
Net Profit Margin
Profitability
21.0% -25.3% Higher Margin PATH
Return on Equity (ROE)
Capital Efficiency
20.0% -27.7% Higher ROE PATH
52-Week Range Position
Momentum
38% ($9–$20) 100% ($16–$31) Stronger Trend CFLT
Beta / 30D Volatility
Risk Regime
0.86β · 30% Vol 0.99β · 4% Vol Lower Realized Risk CFLT
Unified Institutional Score
Composite Signal
58.3 / 100 (HOLD) 62.8 / 100 (BUY) Higher Composite CFLT
Trailing 12M Revenue (USD)
Operating Scale
$1.72B $1.17B FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
82.6% 74.3% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
0.41x PEG · 3.7x EV/Rev 2.16x PEG · 9.4x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$363M ($528M Net Cash) -$338M EBITDA ($3.28 Book/Sh · -27.7% ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon PATH +1.95 pp
PATH: +3.49% · CFLT: +1.54%
3M Horizon CFLT +38.65 pp
PATH: -35.83% · CFLT: +2.82%
6M Horizon CFLT +50.33 pp
PATH: -17.89% · CFLT: +32.44%
1Y Horizon CFLT +50.33 pp
PATH: -17.89% · CFLT: +32.44%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on PATH vs CFLT. Trailing 12-month operating profitability (PATH 9.4% vs CFLT -27.5%) and valuation multiples (PATH 17.4x vs CFLT 46.7x Forward P/E) are benchmarked directly in Pillar 4 below.

PATH ADR TTM Benchmark FX-Normalized USD
TTM Revenue$1.72B
Gross Margin82.6%
Op. Margin9.4%
ROE / Fwd P/E20.0% · 17.4x
CFLT ADR TTM Benchmark FX-Normalized USD
TTM Revenue$1.17B
Gross Margin74.3%
Op. Margin-27.5%
ROE / Fwd P/E-27.7% · 46.7x

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
PATH BREAKDOWN
54d in phase · OBV DISTRIBUTION
Current IV 50.3%
IV Percentile 11th %ile
Put/Call OI Skew 0.49x (Call-Skewed)
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BULLISH
OBV Flow DISTRIBUTION
Exact PATH Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
CFLT UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 0.2%
IV Percentile <1st %ile
Put/Call OI Skew N/A
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact CFLT Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
PATH Moat Profile Scale & Operating Efficiency Moat
Software - Infrastructure Operator
Competes within the Software - Infrastructure value chain with $6.8B market capitalization and 9.4% operating margin.
OpEx & R&D Reinvestment 73.2% of Rev ($1.26B)
90D Engineering Disclosures 0 Published
CFLT Moat Profile Cyclical / Execution-Driven Positioning
Software - Infrastructure Operator
Competes within the Software - Infrastructure value chain with $11.0B market capitalization and -27.5% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published

Investor FAQ PATH vs CFLT Key Questions & Quantitative Answers

As of Nov 16, 2026, Confluent, Inc. (CFLT) captures the overall head-to-head institutional edge over UiPath, Inc. (PATH) on higher Unified Composite conviction (62.8/100 BUY vs. 58.3/100 HOLD) after splitting the core matrix 5–5 (led by Growth & Scale, Options & Positioning), while PATH wins 4–2 across the 6-pillar growth and valuation breakdown. PATH trades at $13.24 (17.4x Forward P/E, 9.4% operating margin) versus CFLT at $30.99 (46.7x Forward P/E, -27.5% operating margin). Growth vs. Quality Trade-Off: CFLT earns the overall head-to-head edge with a stronger Unified Composite Score (62.8/100 BUY vs. PATH 58.3/100 HOLD) and 0.99β · 4% Vol risk profile, whereas PATH leads top-line expansion (+13.4% YoY revenue growth, 0.41x PEG, and 4 of 6 institutional pillars) for higher-beta growth mandates. Technical & Structure Timing Caution: PATH is currently in a Weinstein Distribution regime near a flattening 50-day moving average and Breakdown options structure phase (RSI 47.4); meanwhile CFLT trades in a Markup technical trend (UNCLASSIFIED options phase, RSI 72.9). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

CFLT leads the Growth & Scale pillar: PATH posts +13.4% YoY revenue growth and N/A YoY earnings growth on $1.72B TTM revenue (82.6% gross margin, 9.4% operating margin), compared with CFLT at +20.5% YoY revenue growth and +0.0% YoY earnings growth on $1.17B TTM revenue (74.3% gross margin, -27.5% operating margin). On trailing 12-month operating scale, PATH generates $1.72B in USD-normalized revenue versus $1.17B for CFLT. In operating R&D and SG&A reinvestment, PATH deploys 73.2% of Rev ($1.26B) (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for CFLT.

PATH screens cheaper on headline valuation multiples. PATH trades at 17.4x Forward P/E, 19.6x Trailing P/E, 0.41x PEG, and 3.7x EV/Revenue (21.1% FCF margin), whereas CFLT trades at 46.7x Forward P/E, 61.4x Trailing P/E, 2.16x PEG, and 9.4x EV/Revenue (-29.0% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against PATH (20.0% ROE) versus CFLT (-27.7% ROE) capital efficiency.

In options market volatility and institutional positioning, PATH carries 50.3% implied volatility (11th %ile, Compressed (<25th %ile)), a 0.49x (Call-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a BREAKDOWN options structure phase (0.86β · 30% Vol realized risk). By comparison, CFLT carries 0.2% implied volatility (<1st %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.99β · 4% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.